Skip to Content

Promising Efficacy of Biologicals and Small Molecules for Microscopic Colitis

The study presented in this MEDtalk by Bram Verstockt aimed to evaluate the efficacy of advanced therapies in treating microscopic colitis, particularly in patients who are refractory to or dependent on budesonide, the only approved therapy with a high relapse rate and significant side effects.

Bram Verstockt

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top